Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 23 Feb 2023 18:00 CET |
SOLVAC NOM(RETAIL) | Increase of 2.6 % of the dividend per share in 2022 compared to 2021 | 55201000 Chemicals: Diversified | Change in Capital |
| 23 Feb 2023 18:00 CET |
SOLVAC NOM(RETAIL) | Dividend per aandeel stijgt met 2,6 % in 2022 vergeleken met 2021 | 55201000 Chemicals: Diversified | Change in Capital |
| 23 Feb 2023 17:40 CET |
ASCENCIO | Interim statement at 31/12/2022 - First quarter of financial year 2022-2023 | 35102045 Retail REITs | Income |
| 23 Feb 2023 08:00 CET |
EURONAV | Euronav presentatie over Bijzondere Algemene Vergadering | 50206030 Marine Transportation | Other subject |
| 23 Feb 2023 08:00 CET |
EURONAV | Euronav presentation on Special General Meeting | 50206030 Marine Transportation | Other subject |
| 23 Feb 2023 07:00 CET |
SOLVAY | Solvay fourth quarter and full-year 2022 results | 55201000 Chemicals: Diversified | Corporate life |
| 23 Feb 2023 07:00 CET |
VGP | VGP NV: Financial Result for FY2022 | 35101010 Real Estate Holding and Development | Income |
| 23 Feb 2023 07:00 CET |
BIOSENIC | BioSenic optimizes statistical analysis for its ongoing ALLOB Phase IIb study for high-risk tibial fractures, requiring fewer patients and completes patient recruitment | 20103010 Biotechnology | Other subject |
| 23 Feb 2023 07:00 CET |
BIOCARTIS | Press release Biocartis Group NV: Biocartis announces 2022 results and 2023 outlook | 20101025 Health Services | Other subject |
| 23 Feb 2023 07:00 CET |
ARGENX SE | argenx to Report Full Year 2022 Financial Results and Fourth Quarter Business Update on March 2, 2023 | 20103010 Biotechnology | Other subject |
| 23 Feb 2023 07:00 CET |
SOLVAY | Résultats du T4 et de l’année 2022 | 55201000 Chemicals: Diversified | Corporate life |
| 23 Feb 2023 07:00 CET |
VGP | VGP NV: Financieel Resultaat voor Boekjaar 2022 | 35101010 Real Estate Holding and Development | Income |
| 23 Feb 2023 07:00 CET |
BIOSENIC | BioSenic optimise l’analyse statistique de son étude de Phase IIb en cours avec ALLOB dans les fractures du tibia à haut risque et clôture le recrutement des patients | 20103010 Biotechnology | Other subject |
| 23 Feb 2023 07:00 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis maakt resultaten 2022 en vooruitzichten 2023 bekend | 20101025 Health Services | Other subject |
| 23 Feb 2023 07:00 CET |
SOLVAY | Resultaten Solvay vierde kwartaal en volledig jaar 2022 | 55201000 Chemicals: Diversified | Corporate life |
| 22 Feb 2023 22:30 CET |
MDXHEALTH | MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 | 20103010 Biotechnology | Commercial results |
| 22 Feb 2023 18:30 CET |
UMICORE | Umicore - Déclaration de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 22 Feb 2023 18:30 CET |
UMICORE | Umicore - Transparantieverklaring van BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 22 Feb 2023 18:30 CET |
UMICORE | Umicore - Transparency notification by BlackRock, Inc. | 55201020 Specialty Chemicals | Other subject |
| 22 Feb 2023 17:51 CET |
LOTUS BAKERIES | Disposal of treasury shares | 45102020 Food Products | Other subject |
| 22 Feb 2023 12:00 CET |
NYXOAH SA | Nyxoah Annonce sa Première Réunion avec les Investisseurs et les Analystes | 20102010 Medical Equipment | Other subject |
| 22 Feb 2023 12:00 CET |
NYXOAH SA | Nyxoah Announces Inaugural Investor & Analyst Meeting | 20102010 Medical Equipment | Other subject |
| 22 Feb 2023 08:00 CET |
ONTEX GROUP | Ontex announces details for its Q4 and FY 2022 results publication | 45201020 Personal Products | Meetings / events |
| 22 Feb 2023 07:30 CET |
AGEAS | Ageas publie ses résultats pour l’année 2022 | 30301010 Life Insurance | Other financial transaction |
| 22 Feb 2023 07:30 CET |
AGEAS | eas rapporteert resultaten over 2022 | 30301010 Life Insurance | Other financial transaction |
| 22 Feb 2023 07:30 CET |
AGEAS | Ageas reports full year 2022 results | 30301010 Life Insurance | Other financial transaction |
| 22 Feb 2023 07:00 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis kondigt wijziging in Raad van Bestuur aan | 20101025 Health Services | Other subject |
| 22 Feb 2023 07:00 CET |
BIOCARTIS | Press release Biocartis Group NV: Biocartis announces change in Board composition | 20101025 Health Services | Other subject |
| 21 Feb 2023 22:30 CET |
MDXHEALTH | Déclaration de Transparence d'un Actionnaire de MDxHealth | 20103010 Biotechnology | Corporate life |
| 21 Feb 2023 22:30 CET |
NYXOAH SA | Nyxoah Annonce sa Première Réunion avec les Investisseurs et les Analystes | 20102010 Medical Equipment | Other subject |
| 21 Feb 2023 22:30 CET |
MDXHEALTH | MDxHealth Shareholder Transparency Declaration | 20103010 Biotechnology | Corporate life |
| 21 Feb 2023 22:30 CET |
NYXOAH SA | Nyxoah Announces Inaugural Investor & Analyst Meeting | 20102010 Medical Equipment | Other subject |
| 21 Feb 2023 17:59 CET |
CENERGY | Hellenic Cables s’engage à fournir et à assurer l’installation de systèmes de câbles souterrains XLPE 400 kV et 150 kV pour IPTO | 50202010 Electrical Components | News contracts |
| 21 Feb 2023 17:58 CET |
CENERGY | Hellenic Cables undertakes the supply and installation of XLPE 400 kV and 150 kV underground cable systems for IPTO | 50202010 Electrical Components | News contracts |
| 21 Feb 2023 17:51 CET |
VIOHALCO | Notification de transaction [article 19 du Règlement (UE) n ° 596/2014] | 55102015 Metal Fabricating | Other subject |
| 21 Feb 2023 17:50 CET |
VIOHALCO | Notification of transaction [article 19 of Regulation (EU) No 596/2014] | 55102015 Metal Fabricating | Other subject |
| 21 Feb 2023 08:00 CET |
EURONAV | Euronav sells Suezmax Cap Charles | 50206030 Marine Transportation | Other subject |
| 21 Feb 2023 08:00 CET |
EURONAV | Euronav verkoopt Suezmax Cap Charles | 50206030 Marine Transportation | Other subject |
| 21 Feb 2023 07:00 CET |
BIOSENIC | BioSenic receives EUR 1 million from Pregene in accordance with terminated license agreement and expect new negotiations on common revisited grounds | 20103010 Biotechnology | Other subject |
| 21 Feb 2023 07:00 CET |
BIOSENIC | BioSenic reçoit 1 million d'euros de Pregene conformément à la résiliation de l'accord de licence et s’attend à de nouvelles négociations sur des bases communes revisitées | 20103010 Biotechnology | Other subject |
| 20 Feb 2023 18:30 CET |
IEP INVEST | Geconsolideerde financiële staten op 31 december 2022 | 35101010 Real Estate Holding and Development | Other subject |
| 20 Feb 2023 18:18 CET |
GBL | GBL - Transacties op GBL-aandelen 20-02-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 20 Feb 2023 18:17 CET |
GBL | GBL - Transactions sur actions propres 20-02-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 20 Feb 2023 18:15 CET |
GBL | GBL - Transactions on GBL shares 20-02-2023 | 30202000 Diversified Financial Services | Other financial transaction |
| 20 Feb 2023 18:00 CET |
ACCENTIS | Jaarresultaten 2022 | 35101010 Real Estate Holding and Development | Other subject |
| 20 Feb 2023 17:40 CET |
KBC ANCORA ord | Mise à jour du programme de rachat d’actions propres KBC Ancora jusqu’au 17 février 2023 | 30101010 Banks | Other subject |
| 20 Feb 2023 17:40 CET |
KBC ANCORA ord | Update inkoopprogramma KBC Ancora tot 17 februari 2023 | 30101010 Banks | Other subject |
| 20 Feb 2023 17:40 CET |
KBC ANCORA ord | Update on share repurchase program KBC Ancora until 17 February 2023 | 30101010 Banks | Other subject |
| 20 Feb 2023 12:25 CET |
SHURGARD | 20230220 Shurgard Full Year 2022 Results | 35101010 Real Estate Holding and Development | Commercial results |
| 20 Feb 2023 08:37 CET |
TITAN CEMENT | Programme de rachats d'actions | 50101030 Cement | Other subject |